CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing targeted nanoparticles for the diagnosis and treatment of Alzheimer's Disease. By engineering these nanoparticles to interact with amyloid-beta, it aims to improve therapeutic outcomes and enhance brain delivery mechanisms.
The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative.
It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration.
In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular plaques mainly composed of Aβ are a hallmark of post-mortem brains.
These premises strongly suggest brain Aβ as a possible target for therapy and diag…
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, ORSAY CEDEX
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
CHEMICKY USTAV SLOVENSKEJ AKADEMIEVIED
Slovakia, Bratislava
Type: Research institute
Activity type: Research Organisations
SME: No
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
